Editas Medicine EDIT
NASDAQ EDIT
$2.49 -0.02 (-0.80%)
At close: Oct 22, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020)

Updated

Editas Medicine (EDIT) reported Other Operating Expenses of $2,000 for Q4 2020, up 100.0% from $1,000 a year earlier.

Analysis

Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020) Analysis & Trends

For FY2016, Editas Medicine posted Other Operating Expenses of $40.48 million.

  • The Q4 2020 figure ranks as the highest quarterly Other Operating Expenses since Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Editas Medicine 222.97 Mn -488.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2,000.00
Dec 31, 2019 1,000.00
Dec 31, 2016 26.84 Mn
API Access

Editas Medicine Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=EDIT&period=max&api_key=YOUR_API_KEY